Blog
Germany's Biggest Banker Downgrades JPMorgan and PNC: What You Need to Know
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
Here's Why TherapeuticsMD Inc Is Falling Today
After the company revealed the pricing details of its recently announced common stock offering, shares of TherapeuticsMD (NYSEMKT: TXMD), a small-cap biotech focused on women's health, fell 11% as....
Why Greenhill & Co. Stock Jumped 15% on Tuesday
Shares of Greenhill & Co. (NYSE: GHL) are surging on Tuesday, trading higher by about 15% as of 11 a.m. EDT after the investment bank announced a recapitalization plan that would effectively....
3 Things I Love About the Apple Inc. iPhone 8 Plus
On Sept. 22, my new Apple (NASDAQ: AAPL) iPhone 8 Plus finally arrived. Although both the iPhone 8 and 8 Plus have been accused of being relatively minor enhancements over their respective....
These 3 Energy Stocks Are Ridiculously Cheap
The stock market has been on a record-shattering run this year, setting new all-time highs on what seems like a daily basis. That has pushed valuations up to the point where value-conscious....
3 Ways for Disney Stock to Get Back Above $100
The triple digits were fun while they lasted for Walt Disney (NYSE: DIS) and its shareholders. The stock closed above $100 every single trading day since Dec. 7 last year until buckling under....
Fitbit Wants to Watch Your Step
Fitbit (NYSE: FIT) is finally on the clock. The out-of-favor wearable fitness leader announced on Monday that Fitbit Ionic -- its first full-fledged smartwatch -- is on track to roll out to....
A Big Positive for Apple Inc. After the iPhone 8 Launch
Mobile analytics software vendor Localytics (via MacRumors) just shared some data showing the adoption of Apple's (NASDAQ: AAPL) new iPhone 8 and iPhone 8 Plus as percentages of the overall iOS....
7 Retirement Rules to Live By
"The question isn't at what age I want to retire, it's at what income." -- George ForemanForeman's quip above is funny, but it's also very true -- both for wealthy people like him and for ordinary....
Mattel Stock Hasn't Been This Cheap Since the Financial Crisis
Shares of toymaker Mattel (NASDAQ: MAT), the company behind Barbie, Hot Wheels, and Fisher-Price, have tumbled 54% so far this year. While rival Hasbro has been firing on all cylinders,....
3 Biotech Stocks With Major Catalysts in October
Every month brings plenty of catalysts for several biotech stocks. October is no exception. There are quite a few regulatory decisions and clinical results expected to be announced next....
How Much Do Retailers Actually Pay Hourly Workers?
Target (NYSE: TGT) made news earlier this week by making public plans to increase its minimum hourly wage for all employees to $11 in October. The chain also pledged to increase wages to a....
3 High-Yield Stocks for Conservative Investors
High-yield stocks are generally off limits for risk-averse investors because they tend to be fundamentally unsound types of equities, bringing with them high debt loads, falling top lines, and so....
Payer Pushback Is Weighing Down Retail Pharmacy Stocks
Prescription volume is climbing at Walgreens Boots Alliance (NASDAQ: WBA) and CVS Health (NYSE: CVS), yet growth rates at these pharmacy retailers are slowing. Why aren't retail pharmacies....
2 Tesla Talking Points: A Vegas Forecast and a Potential Win for AMD
In this Market Foolery podcast segment, host Chris Hill gets the lowdown from Motley Fool Asset Management's Bill Barker about the Deutsche Bank Technology Conference he attended last week in Las....
Scholastic's Latest Quarter Was Cursed by Tough Harry Potter Comparisons
In this Market Foolery podcast segment, host Chris Hill and Motley Fool Asset Management's Bill Barker look at the latest readout from children's book giant Scholastic (NASDAQ: SCHL), which....
The Creative Ways Drugmakers Are Delaying Generics
Drugmakers are increasingly embracing new tactics to protect billions of dollars in sales from generic competition. These strategies often involve patent trials, but that's not the only way....
KB Home's Board Is Serious About Quelling CEO Scandals
In this Market Foolery podcast segment, host Chris Hill and Motley Fool Asset Management's Bill Barker consider how an activist board reacts when an exec embarrasses the company. KB Home (NYSE:....
With GM’s President Selling Shares, What Should Investors Do?
In this Market Foolery podcast segment, host Chris Hill and Motley Fool Hidden Gems' Abi Malin take a listener query about General Motors (NYSE: GM) and broaden it: Are stock sales from in and....
Early Evidence That the Amazon-Whole Foods Merger Is a Picture Perfect Marriage
Amazon.com's (NASDAQ: AMZN) purchase of Whole Foods Market looks like a match made in heaven. The first indication the two could be on an extended honeymoon comes from the immediate boost in sales....
Ask a Fool: Why Do Drugmakers Do Interim Clinical Trials?
The cost of clinical trials jumps significantly when drugmakers move from phase 1 to phase 2 and phase 2 to phase 3. To reduce research and development costs, drugmakers are increasingly embracing....
Expect Higher Dividends Before 2017 Ends From These 3 Stocks
Many of the best dividend stocks in the market have impressive track records of growing their payouts over time. A select few have even gotten to the point at which investors can predict exactly....
3 Reasons to Buy the Dip With Exelixis
In just two days, Exelixis (NASDAQ: EXEL) has lost over 15% of its market cap. The tumble for the once-hot biotech stock started last week with a downgrade of the stock by an analyst at Leerink....
Experts Are Watching This Number at Enbridge Inc
Enbridge Inc (NYSE: ENB) is a Canadian oil and gas midstream giant that sports an impressive 4.6% yield -- well more than twice what the broader market is offering investors today. It has big....
How Safe Is Brown-Forman's Dividend?
Dividend investors like reliable businesses, and the alcohol and spirits industry has been a reliable producer of profits for centuries. Brown-Forman (NYSE: BF-A) (NYSE: BF-B) isn't a household....